Mar 1, 2021|

JD Health Enhances O2O Effort for Parkinson’s Disease

Share:

by Vivian Yang

JD Health’s online pharmacy resources will be integrated into the mobile app of Shanghai Huashan Hospital for Parkinson’s disease to improve patients’ accessibility to medication and their overall treatment experience, which was announced on Feb 26 in Shanghai.

The medical platform for Parkinson’s disease is first of its kind in China to integrate online resources in the whole treatment process for Parkinson’s disease, with pharmaceutical services, covering pre-diagnosis, diagnosis and post-diagnosis healthcare management.  The project is the joint effort of JD Health, Huashan Hospital affiliated with Fudan University, and German pharmaceutical manufacturer Boehringer-Ingelheim.

The launch ceremony of the medical platform for Parkinson’s disease 

In the first stage, the project will be focused on the patient service model developed by Huashan Hospital, which has been a pioneer in the diagnosis and treatment of Parkinson’s disease in China for over 50 years, and began to build its online database platform for the disease’s management in 2011. The platform has evolved over the years into a mobile app known as Pawei(帕为), and an internet-based hub that pools multiple disciplines together in the areas of neurology, neurosurgery, rehabilitation, psychology and more to provide a one-stop service for patients with Parkinson’s disease.

Though patients can make doctor appointment easier through this platform and get the prescriptions, many patients said that they could not find certain medicines in their vicinity.

Under the agreement of this project, Pawei will feature a medicine supply section on its landing page which directs users to JD Health’s online care center for Parkinson’s disease where patients can order medication directly from JD Pharmacy. Patients can find almost all medication available on the Chinese market through this platform and enjoy JD’s same-day or next-day delivery service covering more than 90% of areas in the country.

Valuable knowledge and information about Parkinson’s currently available on Pawei will also be made available on JD Health to further promote and facilitate further education around the disease.

“With the development of telemedicine, managing chronic diseases via online channels has proven to be an effective way to save patients’ hospital visiting time,” noted Dr. Ying Mao, president of Huashan Hospital, at the center launch ceremony.

According to Mao, each year, nearly 12,000 Parkinson’s patients come to Huashan Hospital collectively making a total of 30,000 visits. More than half of the patients are from outside of Shanghai. “I make it so the simple and repetitive tasks can be processed online, such as revisiting doctors and dispensing medication, our limited offline hospital resources can be saved for patients who need them most,” Mao added.

It is estimated that there are about three million patients with Parkinson’s in China, , with a prevalence rate of 1.7% among people over 65 years old. The rate is going up with the aging of the Chinese population. According to the WHO’s estimate, the number of patients with Parkinson’s disease in China will reach 5 million by 2030.

 

(vivian.yang@jd.com)

 

 

Share: